Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
Search
:::

楊慕華 (Muh-Hwa Yang)

楊慕華(Muh-Hwa Yang)圖 Return Appointment First Appointment

[Profile]

  • Education
    • Ph.D., Institute of Clinical Medicine; National Yang-Ming University, Taipei, Taiwan, 2006
    • M.D., Faculty of Medicine; National Yang-Ming University, Taipei, Taiwan, 1994
  • Career and Experience
    Current Positions：
    • 2023- Now, Chief, Deparment of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
    • - Now, Senior Vice President and Provost (February 2021-present), National Yang Ming Chiao Tung University, Taipei, Taiwan
    • - Now, Chair Professor (Auguest 2016-present), Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
    • - Now, Director (February 2018-present), Cancer Progression Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan
    • - Now, Adjunct Research Fellow (August 2014-present), Genomic Research Center, Academia Sinica, Taipei, Taiwan
    Experiences：
    • 2015- 2022, Director (November 2015-), Division of Medical Oncology, Department of Oncology, Tapei Veterans General Hospital, Taipei, Taiwan
    • - , Assistant Professor (2007-2010), Associate Professor (2010-2013), Professor (2013-2016), Acting Director (2017-2018), Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan
    • - , Attending Physician (September 2002-March 2015), Director (March 2015-November 2015), Division of Hematology-Oncology, Taipei Veterans General Hospital, Taipei, Taiwan
    • - , Resident (1996-1999), Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
    • - , Chief Resident/Clinical Fellow (1999-2002), Division of Hematology-Oncology, Taipei Veterans General Hospital, Taipei, Taiwan
  • Medical Expertise
    1. Cancer Biology, Medical Oncology, Hematology, Internal Medicine, Head and Neck Cancer, Cancer Metastasis

[Publications]

PubMed

                                                                                                                                                                (*: co-corresponding author) (†: equal contribution)

  1.  Chiu PH, Lai KC, Wang HL, Chang YW, Wu WC, Chen TH, Tsai YS, Song JH, Sun NY, Chau GY, Fang WL, Chen JP, Wang HM, Huang HC, Hsieh MC, Hua CH, Lien MY, Chang YF, Wang HC, Chien CY, Huang TL, Wang CC, Liu YC, Chen JP, Lu WC, Yiu CY, Lin CL, Lou PJ, Chu PY, Wang SC, Hung MC, and Yang MH*. Therapeutic stress triggers tumor STAT1 acetylation to disarm immunotherapy. Cell Rep Med 2025;6:102448.
  2. Yang WH*, Huang BY, Rao HY, Ye P, Chen B, Wang HC, Chung CH, Wu HH, Yen HR, Wang SC, Cha JH, Yan X*, Yang MH*, Hung MC*. Ribonuclease 1 Induces T-Cell Dysfunction and Impairs CD8+ T-Cell Cytotoxicity to Benefit Tumor Growth through Hijacking STAT1. Adv Sci (Weinh). 2025 Apr;12(13):e2404961. doi: 10.1002/advs.202404961. Epub 2025 Feb 11. (SCI)
  3. Liao TT*, Chen YH, Li ZY, Hsiao AC, Huang YL, Hao RX, Tai SK, Chu PY, Shih JW, Kung HJ, Yang MH*. Hypoxia-Induced Long Noncoding RNA HIF1A-AS2 Regulates Stability of MHC Class I Protein in Head and Neck Cancer. Cancer Immunol Res 2024;12:1468-1484. (SCI)
  4. Lu HJ, Hsieh MC, Wang HM, Hsieh JC, Yen CJ, Wu SY, Huang HC, Wang HC, Chu PY, Chen TH, Chien CY, Huang TL, Chang YF, Hua CH, Lien MY, Chen JP, Lu WC, Lin JC, Wang CC, Liu YC, Yang MH*, Lou PJ. Clinical outcomes of cetuximab-based treatment for distant metastatic head and neck squamous cell carcinoma: A real-world study using Taiwan Head Neck Society registry database. Head Neck 2024;46:1063-1073.
  5. Chang YW, Hsiao HW, Chen JP, Tzeng SF, Tsai CH, Wu CY, Hsieh HH, Carmona SJ, Andreatta M, Di Conza G, Su MT, Koni PA, Ho PC, Chen HK*, Yang MH*. A CSF-1R-blocking antibody/IL-10 fusion protein increases anti-tumor immunity by effectuating tumor-resident CD8+ T cells. Cell Rep Med 2023;4:101154. (SCI)
  6. Chung CH, Lin CY, Chen CY, Hsueh CW, Chang YW, Wang CC, Chu PY, Tai SK, Yang MH*. Ferroptosis Signature Shapes the Immune Profiles to Enhance the Response to Immune Checkpoint Inhibitors in Head and Neck Cancer. Adv Sci (Weinh). 2023;10:e2204514. (SCI)
  7. Lee TL, Chen TH, Kuo YJ, Lan HY, Yang MH*, Chu PY*. Tumor-associated tissue eosinophilia promotes angiogenesis and metastasis in head and neck squamous cell carcinoma. Neoplasia 2023; Jan;35:100855.
  8. Cheng HY, Hsieh CH, Lin PH, Chen YT, Hsu DS, Tai SK, Chu PY, Yang MH*. Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance. J Immunother Cancer 2022;10:e004832. (SCI)
  9. Chen JY, Chou HH, Lim SC, Huang YJ, Lai KC, Guo CL, Tung CY, Su CT, Wang J, Liu E, Han HF, Yeh PY, Hu CM, Dunn AR, Frank CW, Wu YC*, Yang MH*, Chang YC*. Multiomic characterization and drug testing establish circulating tumor cells as an ex vivo tool for personalized medicine. iScience 2022;25:105081. (SCI)
  10. Ou DL, Chen CW, Hsu CL, Chung CH, Feng ZR, Lee BS, Cheng AL, Yang MH*, Hsu C*. Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages. J Immunother Cancer 2021;9:e001657. (SCI)
  11. Liao TT, Lin CC, Jiang JK, Yang SH, Teng HW, Yang MH*. Harnessing stemness and PD-L1 expression by AT-rich interaction domain-containing protein 3B in colorectal cancer. Theranostics 2020;10:6095-6112. (SCI)
  12. Li CF, Chen JY, Ho YH, Hsu WH, Wu LC, Lan HY, Hsu DS, Tai SK, Chang YC*, Yang MH*. Snail-induced claudin-11 prompts collective migration for tumour progression. Nat Cell Biol 2019;21:251-262. (SCI)
  13. Hwang WL*, Lan HY, Cheng WC, Huang SC, Yang MH*. Tumor stem-like cell-derived exosomal RNAs prime neutrophils for facilitating tumorigenesis of colon cancer. J Hematol Oncol 2019;12:10. (SCI)
  14. Lee CC, Lin JC, Hwang WL, Kuo YJ, Chen HK, Tai SK, Lin CC, Yang MH*. Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization. Nat Commun 2018;9:3763. (SCI)
  15. Pan YR, Chen CC, Chan YT, Wang HJ, Chien FT, Chen YL, Liu JL, Yang MH*. STAT3-coordinated migration facilitates the dissemination of diffuse large B-cell lymphomas. Nat Commun 2018;9:3696. (SCI)
  16. Hsieh CH, Tai SK, Yang MH*. Snail-overexpressing cancer cells promote M2-like polarization of tumor-associated macrophages by delivering miR-21-abundant exosomes. Neoplasia 2018;20:775-788. (SCI)
  17. Hsu DS, Hwang WL, Yuh CH, Chu CH, Ho YH, Chen PB, Lin HS, Lin HK, Wu SP, Lin CY, Hsu WH, Lan HY, Wang HJ, Tai SK, Hung MC, Yang MH*. Lymphotoxin-beta interacts with methylated EGFR to mediate acquired resistance to cetuximab in head and neck cancer. Clin Cancer Res 2017;23:4388-4401. (SCI)
  18. Chen CC, Gau JP, You JY, Huang CE, Chen YY, Lo WH, Cheng YH, Tsai PS, Chou HJ, Tseng YT, Lung J*, Yang MH*. Favorable clinical outcome and unique characteristics in association with Twist1 overexpression in de novo acute myeloid leukemia. Blood Cancer J 2015; 5: e339. (SCI)
  19. Hsu DS, Wang SJ, Tai SK, Chou CH, Hsieh CH, Chiu PH, Chen NJ, Yang MH*. Acetylation of Snail modulates the cytokinome of cancer cells to enhance the recruitment of macrophages. Cancer Cell 2014;26:534-48. (SCI)
  20. Hwang WL, Jiang JK, Yang SH, Huang TS, Lan HY, Teng HW, Yang CY, Tsai YP, Lin CH, Wang HW*, Yang MH*. MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol.. (SCI)
  21. Yang WH, Lan HY, Huang CH, Tai SK, Tzeng CH, Kao SY, Wu KJ, Hung MC, Yang MH*. RAC1 activation mediates Twist1-induced cancer cell migration. Nat Cell Biol 2012;14:366-374. (SCI)